Site Wide Notice

Coronavirus Update - 07th April 2020

We understand our customers concerns relating to the spread of COVID-19 and would like to assure you that we are located in one of the least affected areas of the UK and are open for business as usual.

Click here for latest information

Our work and case studies

Challenge: Process chemistry route to API required hydrogenation, then salt formation. The hydrogenation product was chemically unstable until the salt was formed. On a large scale, this was adequately controlled.

In radiochemical trials, the larger dilution and higher catalyst loading required for the very small-scale synthesis led to increased degradation of the unstable intermediate and unacceptable yield.

Customer:

US Biopharmaceutical Company

Outcome:

A flow hydrogenation reactor was used; as the chemically unstable product was formed it was fed directly into the salt formation vessel. This greatly reduced degradation.

Successful [14C]synthesis was carried out to support both non-clinical and clinical trials. 

 

ICMS Radiosynthesis Case Study